NCT06415500View on ClinicalTrials.gov

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

December 6, 2025

Study Completion Date

December 6, 2026

Conditions
Gynecologic Cancer
Interventions
DRUG

NK042

NK042 intraperitoneal infusion on Days 0,7 and 14.

Trial Locations (1)

230001

Anhui Provincal Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV

NCT06415500 - A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites | Biotech Hunter | Biotech Hunter